started · updated
Qatar recalls all shipments of Ferinject iron medication
The Qatari Ministry of Public Health has announced a recall of all batches of Ferinject 50 mg/mL. Laboratory tests revealed that the intravenous iron replacement medication is non-compliant with the manufacturer's stated chemical specifications.
Ferinject, which contains ferric carboxymaltose, is used to treat iron-deficiency anemia in patients for whom oral supplements are ineffective or clinically inappropriate. The recall follows other recent pharmaceutical actions in the region, including the recall of Isotears-Plus eye drops and Clasgen 0.05% eye drops due to manufacturing defects and data integrity issues.